NEW YORK, July 27, 2026, 15:00 EDT
- Palantir gained 6.9% to close at $131.36 as the Invesco QQQ Trust slipped 0.7%.
- Oppenheimer projects second-quarter revenue will rise by 84% to 85%, according to a preliminary estimate.
- Options pricing suggests Palantir shares could swing 9.6% following its August 3 earnings release.
Palantir Technologies Inc. NASDAQ:PLTR climbed 6.9% to $131.36 in afternoon trading on Monday. The share surge came after Oppenheimer Holdings Inc. (NYSE:OPY) issued an optimistic earnings outlook. The move increased Palantir’s market capitalization by roughly $21.7 billion. U.S. markets continued regular trading hours.
Param Singh, an analyst at Oppenheimer, anticipates another quarterly outperformance and an increased full-year outlook. Singh reiterated an Outperform rating and set a price target of $200.

Such optimism comes with a high price tag. Palantir trades at a $337.8 billion market capitalization, which is 44.1 times the midpoint of its projected 2026 revenue.
Singh anticipates annual growth to exceed 75%, compared to Palantir’s present projection of 71%. This would result in 2026 revenue surpassing $7.832 billion, which is $176 million higher than the current midpoint of guidance.
With the share price steady, the multiple remains at 43.1 times. The market value added on Monday was roughly 123 times the minimum revenue increase. This is not a direct comparison. It highlights the scale of growth investors are still expecting beyond 2026.
| Investor benchmark | Value | Comparison |
|---|---|---|
| Monday’s market capitalization | $337.8 billion | Increase of about $21.7 billion |
| Midpoint for 2026 guidance | $7.656 billion | 44.1x sales |
| Revenue with 75% year-over-year growth | $7.832 billion | 43.1x sales |
| August 3 options anticipated movement | ±9.6% | Approximately $118.75–$143.97 |
Initial estimate: Singh anticipates second-quarter revenue will rise by 84% to 85%. The management midpoint signals roughly 79%. According to his findings, Palantir appeared “relatively immune” to the deal postponements experienced by other software providers. TipRanks
Singh projects U.S. commercial growth to exceed 135%. Growth for the U.S. government segment is likely to be in the low 80s. International government appetite appears weaker, as European customers look at regional options.
The challenge is set by a robust opening quarter. Revenue increased 85% to $1.633 billion. U.S. commercial sales jumped 133%, and U.S. government sales climbed 84%. Adjusted operating margin stood at 60%.
Palantir forecasted second-quarter revenue in the range of $1.797 billion to $1.801 billion. In May, the company increased its full-year outlook to between $7.650 billion and $7.662 billion. Chief Executive Alex Karp pointed to confidence in an “accelerating U.S. market.” SEC
Palantir benefited from a broader recovery in software stocks. Shares of ServiceNow Inc. NYSE:NOW climbed 8.9%. Datadog Inc. NASDAQ:DDOG was up 3.4%, and Snowflake Inc. NYSE:SNOW increased by 1.4%. The Invesco QQQ Trust NASDAQ:QQQ slipped 0.7%.
Monday’s advance was not enough to offset last week’s decline. Palantir was still trading 2.6% under its July 20 closing price of $134.85. By Friday, it had regained around 71% of the drop.
Options imply a 9.6% swing for the August 3 report. With shares at $131.36, the projected move is approximately $12.61 up or down. This sets the implied range between $118.75 and $143.97.
The previous two reports saw actual stock movements lag behind expectations set by options. Following the May earnings, shares declined by 5.0%. After the results in February, shares were down 6.9%.
A new trial emerged in Britain on Monday. Research by the Health Foundation reported no significant progress in hospital discharge efficiency at NHS trusts implementing Palantir’s software. Palantir responded, stating that the study misinterpreted the intended application of its tool.
Risks: The stock’s valuation offers limited upside for a standard outperformance. Palantir reports that the majority of its contracts include termination clauses. Weaker international government demand and regulatory attention in the UK may further hinder new contract wins.
The report on August 3 will need to surpass $1.801 billion to satisfy expectations. Investors are also looking for a significant upgrade to guidance. Even with Singh’s projection, the stock is still trading at over 43 times projected 2026 sales.